NCT01306084
- Conditions
- Adenoviridae Infections, Anogenital Herpes, COVID-19, +22 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Herpes Labialis
Explore clinical trials studying Herpes Labialis. Study availability and eligibility vary by location and protocol.
26 public trials
1 recruiting study
Herpes Labialis trial results
NCT03661541
- Conditions
- DNA Virus Infections, HSV, Herpes Labialis, +11 more
- Locations
-
- Prism Clinical Research, LLC Saint Paul, Minnesota, United States
NCT02965781
- Conditions
- Cold Sore, DNA Virus Infections, Herpes Labialis, +11 more
- Locations
-
- Stanford Medicine Outpatient Center Redwood City, California, United States
- International Research Partners, LLC Doral, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Quality Clinical Research, Inc Omaha, Nebraska, United States
NCT02265913
- Conditions
- DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
- Locations
-
- Quality Clinical Research Inc Omaha, Nebraska, United States
NCT02871492
- Conditions
- DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
- Locations
-
- Scottsdale, Arizona, United States
- Santa Rosa, California, United States
- Pinellas Park, Florida, United States
- Edina, Minnesota, United States
NCT00878072
- Conditions
- DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
- Locations
-
- Women's Health Care at Frost Street San Diego, California, United States
- Children's Memorial Hospital Chicago, Illinois, United States
- Medisphere Medical Research Center, LLC Evansville, Indiana, United States
- Clayton Medical Research St Louis, Missouri, United States
NCT02483182
- Conditions
- DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
- Locations
-
- Dermatology out-patients clinic, Lev Hayasmin MC Netanya, Israel
NCT00711776
- Conditions
- DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
- Locations
-
- GSK Investigational Site Tokyo, Japan
Completed
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
NCT00306293
- Conditions
- Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +21 more
- Locations
-
- GSK Investigational Site Anaheim, California, United States
- GSK Investigational Site Carmichael, California, United States
- GSK Investigational Site Fair Oaks, California, United States
- GSK Investigational Site Sacramento, California, United States
NCT03310294
- Conditions
- DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
- Locations
-
Not specified